[
  {
    "ts": null,
    "headline": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
    "summary": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=4a0c20187423a69b09d7aaba5c57b1a7486fff95e328d4257e20898c6ff381ab",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750180020,
      "headline": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
      "id": 135368965,
      "image": "",
      "related": "DGX",
      "source": "MarketWatch",
      "summary": "Quest Diagnostics Inc. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=4a0c20187423a69b09d7aaba5c57b1a7486fff95e328d4257e20898c6ff381ab"
    }
  },
  {
    "ts": null,
    "headline": "DGX Stock Up on New Blood Test Development Deal With MD Anderson",
    "summary": "DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.",
    "url": "https://finnhub.io/api/news?id=ddc7875369ba18d40dfac30ae9d7ca99a96b7717d02906d0648750b6b711f5bb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750163940,
      "headline": "DGX Stock Up on New Blood Test Development Deal With MD Anderson",
      "id": 135336869,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "DGX stock rises on a new partnership with MD Anderson to develop a blood test targeting multiple cancer risks.",
      "url": "https://finnhub.io/api/news?id=ddc7875369ba18d40dfac30ae9d7ca99a96b7717d02906d0648750b6b711f5bb"
    }
  },
  {
    "ts": null,
    "headline": "The 5 Most Interesting Analyst Questions From Quest’s Q1 Earnings Call",
    "summary": "Quest Diagnostics delivered a strong start to the year, with revenue and adjusted profit both coming in above Wall Street expectations. Management attributed the robust performance to higher sales volumes, contributions from recent acquisitions, and expanded partnerships with large enterprise accounts. CEO Jim Davis pointed to particularly strong demand in advanced diagnostics, new health plan contracts, and the successful integration of acquired businesses as key factors supporting growth. Davi",
    "url": "https://finnhub.io/api/news?id=e16fc63b9feda0c4bdaba76c10bee62fc3e1606a6437b4c8579454d78dc537a5",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750162291,
      "headline": "The 5 Most Interesting Analyst Questions From Quest’s Q1 Earnings Call",
      "id": 135336871,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "DGX",
      "source": "Yahoo",
      "summary": "Quest Diagnostics delivered a strong start to the year, with revenue and adjusted profit both coming in above Wall Street expectations. Management attributed the robust performance to higher sales volumes, contributions from recent acquisitions, and expanded partnerships with large enterprise accounts. CEO Jim Davis pointed to particularly strong demand in advanced diagnostics, new health plan contracts, and the successful integration of acquired businesses as key factors supporting growth. Davi",
      "url": "https://finnhub.io/api/news?id=e16fc63b9feda0c4bdaba76c10bee62fc3e1606a6437b4c8579454d78dc537a5"
    }
  }
]